Kim, B., Ryu, K. J., Lee, S., & Kim, T. (2021). Changes in telomere length and senescence markers during human ovarian tissue cryopreservation. Scientific reports. https://doi.org/10.1038/s41598-021-81973-3
Kim B, Ryu KJ, Lee S, Kim T. Changes in telomere length and senescence markers during human ovarian tissue cryopreservation. Scientific reports. 2021. doi:10.1038/s41598-021-81973-3
Kim, Boram, et al. "Changes in telomere length and senescence markers during human ovarian tissue cryopreservation." Scientific reports, 2021.
For EndNote, Zotero or Mendeley:
Open access
No open license is recorded for this paper. Reuse terms are set by the publisher.
Open Access
Free full text on PubMed Central (PMC7838193)
RRM Academy Synopsis
Slow freezing of human ovarian tissue is linked to DNA damage
In a laboratory study of ovarian tissue from 10 women, slow freezing was associated with shorter telomeres and more DNA damage than in fresh tissue. Senescence proteins also shifted in these 10 frozen samples. Telomeres cap the ends of chromosomes.
Key Findings
Mean telomere length fell significantly after cryopreservation compared with fresh tissue (p = 0.001).
Frozen tissue showed a mean 12.8% shorter telomere length than fresh ovarian tissue.
The mean percentage of γ-H2AX-positive cells was 51.029 ± 10.62 in slow-frozen tissue and 1.667 ± 2.887 in control tissue (p < 0.001).
The mean TUNEL-positive area was 0.115 ± 0.089 in slow-frozen tissue and 0.014 ± 0.010 in control tissue (p = 0.006).
Levels of p53, p16, and p21 proteins rose while phospho-pRb fell in the frozen tissue.
Interpretation
The authors describe an experimental laboratory study of ovarian tissue pieces from 10 women aged 16 to 34 who had benign ovarian surgery. Each woman's tissue was measured before and after slow freezing. The work recorded cell and protein changes. It involved no transplant and no pregnancy outcomes. Damage appeared in the granulosa cells around follicles, with none seen in the oocyte. The authors note the small number of patients.
RRM Context
Restorative reproductive medicine values care that protects the health of reproductive tissue. Ovarian tissue freezing is offered before cancer treatment. This study adds a cellular measure of what freezing does to the tissue. Telomere length and senescence markers give researchers a way to track tissue health in future work.
Our editorial summary of this paper, not the article's abstract.
Abstract
Ovarian tissue cryopreservation is considered as a useful option to preserve fertility for cancer patients. This study purposed to evaluate the change of telomere length and senescence markers during human ovarian tissue cryopreservation. Ovarian tissues were obtained from women who underwent benign ovarian surgery in the gynecology research unit of a university hospital with prior consent and IRB approval. DNA was extracted from the ovarian tissues using a DNeasy tissue kit and telomere lengths in the DNA samples were determined by real time PCR before and after cryopreservation. All tissues were stained with hematoxylin-eosin and subjected to immunohistochemistry and TUNEL assays. Other senescence markers, including p53, p16, p21, and phospho-pRb proteins, were evaluated using western blot analysis. Ovarian tissues were collected from ten patients and prepared for slow freezing with the same size of diameter 4 mm and 1 mm thickness. Mean age of patients was 26.7 ± 6.2 years (range, 16-34 years), and ovarian tissues were cryopreserved and thawed 4 weeks after cryopreservation. The mean telomere length was significantly decreased after cryopreservation (9.57 ± 1.47 bp vs. 8.34 ± 1.83 bp, p = 0.001). Western blot analysis revealed that p53, p16, and p21 proteins increased and phospho-pRb protein expression decreased after ovarian tissue cryopreservation. Ovarian tissue cryopreservation and transplantation is regarded as one of promising options for fertility preservation. However, clinicians and researchers should be aware of possible irreversible DNA changes such as shortening of telomere length and alterations of other senescence markers in human ovarian tissues.